Development and characterization of lipidic cochleate containing recombinant factor VIII

Biochimica et Biophysica Acta - Biomembranes

Volumn 1768, Issue 11, 2007, Pages 2890-2898

  Miclea, Razvan D ^a   Varma, Prashant R ^b   Peng, Aaron ^b   Balu Iyer, Sathy V ^a,b  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Acrylamide quenching; B domain deleted recombinant factor VIII; Cochleate cylinder; Epitope shielding; Laurdan; Protein formulation

Indexed keywords

ACRYLAMIDE; CALCIUM ION; PHOSPHATIDYLSERINE; RECOMBINANT BLOOD CLOTTING FACTOR 8;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOPHYSICS; CONTROLLED STUDY; DOSE RESPONSE; DRUG STABILITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FREEZE THAWING; HEMOPHILIA; IN VIVO STUDY; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE;

ANIMALS; DRUG STABILITY; FACTOR VIII; HEMOPHILIA A; LIPOSOMES; MICE; PHOSPHATIDYLSERINES; PROTEIN CONFORMATION; RECOMBINANT PROTEINS;

MURINAE; MUS;

EID: 35848960381     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2007.08.001     Document Type: Article

References (36)

1. Kaufman R.J. Biological regulation of factor VIII activity. Annu. Rev. Med. 43 (1992) 325-339
2. Kaufman R.J., Wasley L.C., and Dorner A.J. Synthesis, processing, and secretion of recombinant human factor VIII expressed in mammalian cells. J. Biol. Chem. 263 (1988) 6352-6362
3. Larner A.J. The molecular pathology of haemophilia. Q. J. Med. 63 (1987) 473-491
4. Klinge J., Ananyeva N.M., Hauser C.A., and Saenko E.L. Hemophilia A-from basic science to clinical practice. Semin. Thromb. Hemost. 28 (2002) 309-322
5. Sandberg H., Almstedt A., Brandt J., Castro V.M., Gray E., Holmquist L., Lewin M., Oswaldsson U., Mikaelsson M., Jankowski M.A., Bond M., and Scoble H.A. Structural and functional characterization of B-domain deleted recombinant factor VIII. Semin. Hematol. 38 (2001) 4-12
6. Jacquemin M.G., and Saint-Remy J.M. Factor VIII immunogenicity. Haemophilia 4 (1998) 552-557
7. Lollar P., Healey J.F., Barrow R.T., and Parker E.T. Factor VIII inhibitors. Adv. Exp. Med. Biol. 489 (2001) 65-73
8. Balasubramanian S.V., Miclea R.D., and Purohit V.S. Formulation and Delivery Issues of Therapeutic Proteins (2006), John Willey and Sons
9. Purohit V.S., and Balasubramanian S.V. Interaction of dicaproyl phosphatidylserine with recombinant factor VIII and its impact on immunogenicity. Aaps. J. 8 (2006) E362-E370
10. Purohit V.S., Ramani K., Sarkar R., Kazazian Jr. H.H., and Balasubramanian S.V. Lower inhibitor development in hemophilia A mice following administration of recombinant factor VIII-O-phospho-l-serine complex. J. Biol. Chem. 280 (2005) 17593-17600
11. Stoilova-McPhie S., Villoutreix B.O., Mertens K., Kemball-Cook G., and Holzenburg A. 3-Dimensional structure of membrane-bound coagulation factor VIII: modeling of the factor VIII heterodimer within a 3-dimensional density map derived by electron crystallography. Blood 99 (2002) 1215-1223
12. Purohit V.S., Ramani K., Kashi R.S., Durrani M.J., Kreiger T.J., and Balasubramanian S.V. Topology of factor VIII bound to phosphatidylserine-containing model membranes. Biochim. Biophys. Acta 1617 (2003) 31-38
13. Papahadjopoulos D., Vail W.J., Jacobson K., and Poste G. Cochleate lipid cylinders: formation by fusion of unilamellar lipid vesicles. Biochim. Biophys. Acta 394 (1975) 483-491
14. Zarif L., Graybill J.R., Perlin D., Najvar L., Bocanegra R., and Mannino R.J. Antifungal activity of amphotericin B cochleates against Candida albicans infection in a mouse model. Antimicrob. Agents. Chemother. 44 (2000) 1463-1469
15. Zarif L. Elongated supramolecular assemblies in drug delivery. J. Control. Release 81 (2002) 7-23
16. Mannino R.J., and Gould-Fogerite S. Lipid matrix-based vaccines for mucosal and systemic immunization. Pharm. Biotechnol. 6 (1995) 363-387
17. Santangelo R., Paderu P., Delmas G., Chen Z.W., Mannino R., Zarif L., and Perlin D.S. Efficacy of oral cochleate-amphotericin B in a mouse model of systemic candidiasis. Antimicrob. Agents Chemother. 44 (2000) 2356-2360
18. Segarra I., Movshin D.A., and Zarif L. Pharmacokinetics and tissue distribution after intravenous administration of a single dose of amphotericin B cochleates, a new lipid-based delivery system. J. Pharm. Sci. 91 (2002) 1827-1837
19. Ramani K., and Balasubramanian S.V. Fluorescence properties of Laurdan in cochleate phases. Biochim. Biophys. Acta 1618 (2003) 67-78
20. Bartlett G.R. Phosphorus assay in column chromatography. J. Biol. Chem. 234 (1959) 466-468
21. Lakowicz J., Principles of fluorescence spectroscopy., 2nd ed., Kluwer Academic/Plenum, New York, 1999.
22. Purohit V.S., Middaugh C.R., and Balasubramanian S.V. Influence of aggregation on immunogenicity of recombinant human factor VIII in hemophilia A mice. J. Pharm. Sci. 95 (2006) 358-371
23. Over J. Methodology of the one-stage assay of factor VIII (VIII:C). Scand. J. Haematol. Suppl. 41 (1984) 13-24
24. Rosen S. Assay of factor VIII:C with a chromogenic substrate. Scand. J. Haematol. Suppl. 40 (1984) 139-145
25. Grillo A.O., Edwards K.L., Kashi R.S., Shipley K.M., Hu L., Besman M.J., and Middaugh C.R. Conformational origin of the aggregation of recombinant human factor VIII. Biochemistry 40 (2001) 586-595
26. Ramani K., Purohit V.S., Miclea R.D., Middaugh C.R., and Balasubramanian S.V. Lipid binding region (2303-2332) is involved in aggregation of recombinant human FVIII (rFVIII). J. Pharm. Sci. 94 (2005) 1288-1299
27. K. Ramani, R.D. Miclea, V.S. Purohit, D.E. Mager, R.M. Straubinger, S.V. Balu-Iyer, Phosphatidylserine containing liposomes reduce immunogenicity of recombinant human factor VIII (rFVIII) in a murine model of hemophilia A. J. Pharm. Sci. (In press) (http://www3.interscience.wiley.com/cgi-bin/fulltext/115805597/PDFSTART), doi:10.1002/jps.21102.
28. Parasassi T., De Stasio G., d'Ubaldo A., and Gratton E. Phase fluctuation in phospholipid membranes revealed by Laurdan fluorescence. Biophys. J. 57 (1990) 1179-1186
29. Parasassi T., De Stasio G., Ravagnan G., Rusch R.M., and Gratton E. Quantitation of lipid phases in phospholipid vesicles by the generalized polarization of Laurdan fluorescence. Biophys. J. 60 (1991) 179-189
30. del Mar Martinez-Senac M., Corbalan-Garcia S., and Gomez-Fernandez J.C. Conformation of the C-terminal domain of the pro-apoptotic protein Bax and mutants and its interaction with membranes. Biochemistry 40 (2001) 9983-9992
31. Butterfield D.A., Boyd-Kimball D., and Castegna A. Proteomics in Alzheimer's disease: insights into potential mechanisms of neurodegeneration. J. Neurochem. 86 (2003) 1313-1327
32. Mouradian S. Lab-on-a-chip: applications in proteomics. Curr. Opin. Chem. Biol. 6 (2002) 51-56
33. Sebela M., Stosova T., Havlis J., Wielsch N., Thomas H., Zdrahal Z., and Shevchenko A. Thermostable trypsin conjugates for high-throughput proteomics: synthesis and performance evaluation. Proteomics 6 (2006) 2959-2963
34. Slysz G.W., Lewis D.F., and Schriemer D.C. Detection and identification of sub-nanogram levels of protein in a nanoLC-trypsin-MS system. J. Proteome. Res. 5 (2006) 1959-1966
35. Szebeni J. The interaction of liposomes with the complement system. Crit. Rev. Ther. Drug Carr. Syst. 15 (1998) 57-88
36. Bi L., Lawler A.M., Antonarakis S.E., High K.A., Gearhart J.D., and Kazazian Jr. H.H. Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A. Nat. Genet. 10 (1995) 119-121